Flemming Steen Jensen - 11 May 2026 Form 4 Insider Report for Ascendis Pharma A/S (ASND)

Reporting relationship: EVP & Product Supply and Quality
Issuer ticker: ASND
Reported as of: 11 May 2026
Net transaction value: -$4,641,021
SEC form: 4
Accepted by SEC: 12 May 2026, 16:08:41 UTC
Prior SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Michael Wolff Jensen as attorney-in-fact for Flemming Jensen

Key filing fact

Flemming Steen Jensen filed Form 4 for Ascendis Pharma A/S (ASND) on 12 May 2026.

Key facts

This page summarizes Flemming Steen Jensen's Form 4 filing for Ascendis Pharma A/S (ASND).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 12 May 2026, 16:08.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001965612 Primary reporting owner

Shares, units, or other non-derivative securities reported in this filing.

ASND transaction

Sale

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

SEC remarks

EVP & Product Supply and Quality